fregime

What actually happened to the stocks you care about: every claim cited, corroboration counted, never opinions.

SONAMLTD · NSE

SONAM

₹64.44

-0.49%

Close (EOD), as of 26 Aug 2026 · source

Not in active coverage. Cited reporting has mentioned SONAM, the record of those mentions is below. Your interest is logged; coverage expands by demand.

Mentions in cited reporting

Sonam Srivastava, founder of Wright Research, believes industrials present a strong case for fresh investments after Q1FY27 earnings, supported by robust contracted order books across defence procurement, power transmission and grid infrastructure, along with clear evidence of revenue conversion…

earningsmoneycontrol.comsingle-source report18 Aug 2026

Pharmaceuticals offer stable domestic demand alongside export revenue benefits from currency movements, according to Sonam Srivastava, founder of Wright Research.

earningsmoneycontrol.comsingle-source report18 Aug 2026

Every claim carries its citation

This page lists where cited reporting has mentioned SONAM. It is not the full dossier: developments here are single mentions, not corroborated records. We compile and cite; we do not opine.

fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.